project id: TCGA-KIRP; case submitter id: TCGA-G7-7501; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.61; rna integrity number: 9.3; age at index: 55; days to birth: -20165; days to death: 624; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1956; age at diagnosis: 20165; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage III; ajcc clinical t: T2a; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 416.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; cigarettes per day: 0.9315068493150684; pack years smoked: 17.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 1.5; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-G7-7501-01A-11; percent lymphocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0;